The estimated Net Worth of Kelli Mari Howell is at least $1.12 Millón dollars as of 11 March 2019. Ms. Howell owns over 100,000 units of Alphatec Inc stock worth over $1,120,738 and over the last 7 years she sold ATEC stock worth over $0. In addition, she makes $0 as Executive Vice President - Clinical Strategies at Alphatec Inc.
Kelli has made over 1 trades of the Alphatec Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 100,000 units of ATEC stock worth $259,000 on 11 March 2019.
The largest trade she's ever made was buying 100,000 units of Alphatec Inc stock on 11 March 2019 worth over $259,000. On average, Kelli trades about 7,692 units every 0 days since 2018. As of 11 March 2019 she still owns at least 205,640 units of Alphatec Inc stock.
You can see the complete history of Ms. Howell stock trades at the bottom of the page.
Kelli Mari Howell serves as Executive Vice President - Clinical Strategies of the Company. For the 18 years prior to joining us, she held various management positions at NuVasive, Inc., including Vice President, Research & Health Informatics from January 2017 to March 2018, Vice President, Research & Education from February 2015 to January 2017, and Vice President, Research from April 2012 to February 2015. Prior to NuVasive, Ms. Howell was involved in research at Orthopedic Biomechanics Laboratory (OBL), Beth Israel Deaconess Medical Center in Boston. Ms. Howell received a M.S. degree in Biomedical Engineering from Boston University and a B.A. degree in Engineering Sciences from Dartmouth College.
Kelli Howell is 46, she's been the Executive Vice President - Clinical Strategies of Alphatec Inc since 2018. There are 20 older and 6 younger executives at Alphatec Inc. The oldest executive at Alphatec Holdings Inc is Ward Woods, 77, who is the Independent Director.
Kelli's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.
Over the last 18 years, insiders at Alphatec Inc have traded over $1,216,108,242 worth of Alphatec Inc stock and bought 24,460,197 units worth $141,338,962 . The most active insiders traders include Mortimer Iii Berkowitz, John Foster y Llc Hgp. On average, Alphatec Inc executives and independent directors trade stock every 24 days with the average trade being worth of $1,610,824. The most recent stock trade was executed by Evan Bakst on 23 August 2024, trading 35,000 units of ATEC stock currently worth $201,600.
as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com
Alphatec Inc executives and other stock owners filed with the SEC include: